Litcius/Paper detail

How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States

Suzan M. Walters, David Frank, Marisa Felsher, Jessica Jaiswal, Scott Fletcher, Alex S. Bennett, Samuel R. Friedman, Lawrence J. Ouellet, Danielle C. Ompad, Wiley D. Jenkins, Mai T. Pho

2023International Journal of Drug Policy25 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Hepatitis C virus (HCV) infection has increased among persons who inject drugs (PWID) in the United States with disproportionate burden in rural areas. We use the Risk Environment framework to explore potential economic, physical, social, and political determinants of hepatitis C in rural southern Illinois. METHODS: Nineteen in-depth semi-structured interviews were conducted with PWID from August 2019 through February 2020 (i.e., pre-COVID-19 pandemic) and four with key informants who professionally worked with PWID. Interviews were recorded, professionally transcribed, and coded using qualitative software. We followed a grounded theory approach for coding and analyses. RESULTS: We identify economic, physical, policy, and social factors that may influence HCV transmission risk and serve as barriers to HCV care. Economic instability and lack of economic opportunities, a lack of physically available HCV prevention and treatment services, structural stigma such as policies that criminalize drug use, and social stigma emerged in interviews as potential risks for transmission and barriers to care. CONCLUSION: The rural risk environment framework acknowledges the importance of community and structural factors that influence HCV infection and other disease transmission and care. We find that larger structural factors produce vulnerabilities and reduce access to resources, which negatively impact hepatitis C disease outcomes.

Topics & Concepts

Stigma (botany)Qualitative researchHepatitis CPandemicSocioeconomic statusSocial stigmaEnvironmental healthRural areaMedicineEconomic growthDiseaseInfectious disease (medical specialty)SociologyFamily medicineVirologyCoronavirus disease 2019 (COVID-19)PsychiatryEconomicsPopulationSocial scienceHuman immunodeficiency virus (HIV)PathologyHepatitis C virus researchHIV, Drug Use, Sexual RiskDiabetes Management and Education